EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 3.0

The therapeutic agents that target ATP-sensitive potassium channels

Hussein N Rubaiy

Acta Pharmaceutica · 01.03.2016 · 66 (1) · 23-34

DOI: 10.1515/acph-2016-0006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica, online erschienen am 07.03.2016. Verfasst von Hussein N Rubaiy. Beteiligte Einrichtung: School of Medicine, The Leeds Institute of Cardiovascular and Metabolic Medicine, Univiersity of Leeds, U.K. h.rubaiy@leeds.ac.uk. Die Arbeit wurde bisher 60-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ATP-sensitive potassium (K ATP ) channels are a major drug target for the treatment of type-2 diabetes. K ATP channels are ubiquitously expressed and link the metabolic state to electrical excitability. In pancreatic β-cells, K ATP channels are crucial in the regulation of glucose-induced insulin secretion. Also, K ATP channels are involved in the protection against neuronal seizures and ischaemic stress in the heart, brain and in the regulation of vascular smooth muscle tone. Functional K ATP channels are hetero-octamers composed of two subunits, a pore forming Kir6, which is a member of the inwardly rectifying potassium channels family, and a regulatory sulphonylurea receptor (SUR). In response to nucleotides and pharmaceutical agonists and antagonists, SUR allosterically regulates channel gating. The allosteric communication pathways between these two heterologus proteins in K ATP channels are still poorly understood. This review will highlight the therapeutic agents that target K ATP channels and are used to treat diabetes and cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2Drug Delivery SystemsHumansIon Channel GatingKATP ChannelsPharmaceutical PreparationsSulfonylurea Receptors

Substanzen

KATP ChannelsPharmaceutical PreparationsSulfonylurea Receptors

Autor:innen und Institutionen

  • School of Medicine, The Leeds Institute of Cardiovascular and Metabolic Medicine, Univiersity of Leeds, U.K. h.rubaiy@leeds.ac.uk

Zitieren

APA

Rubaiy, H. N. (2016). The therapeutic agents that target ATP-sensitive potassium channels. Acta Pharmaceutica, 66(1), 23-34. https://doi.org/10.1515/acph-2016-0006

Vancouver

Rubaiy HN. The therapeutic agents that target ATP-sensitive potassium channels. Acta Pharmaceutica. 2016;66(1):23-34. doi:10.1515/acph-2016-0006

BibTeX
@article{Rubaiy2016,
  author = {Rubaiy, Hussein N},
  title = {The therapeutic agents that target ATP-sensitive potassium channels},
  journal = {Acta Pharmaceutica},
  year = {2016},
  volume = {66},
  number = {1},
  pages = {23--34},
  doi = {10.1515/acph-2016-0006}
}
Kostenlos starten →